Cryofocus Medtech to Review 1H26 Interim Results and Potential Dividend on 28 August 2026

Bulletin Express
08/18

Cryofocus Medtech (Shanghai) Co., Ltd. has scheduled a board meeting for 28 August 2026. Directors will evaluate and approve the Group’s interim financial results for the six months ended 30 June 2026 and deliberate on a possible interim dividend declaration.

The board currently consists of Executive Directors LI Kejian (Chairman), ZHU Jun and LIU Wei; Non-executive Directors LV Shiwen and ZHAO Chunsheng; and Independent Non-executive Directors GAO Dayong, LIANG Hsien Tse Joseph, QIN Zheng and HU Henan.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10